메뉴 건너뛰기




Volumn 106, Issue 5, 2012, Pages 858-866

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models

Author keywords

apoptosis; barasertib; docetaxel; scheduling; Selumetinib; temozolomide

Indexed keywords

BARASERTIB; DOCETAXEL; GEMCITABINE; HISTONE H2AX; SELUMETINIB; TEMOZOLOMIDE;

EID: 84863411136     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.8     Document Type: Article
Times cited : (92)

References (34)
  • 2
    • 19644397029 scopus 로고    scopus 로고
    • Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling
    • DOI 10.1038/sj.onc.1208544
    • Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE (2005) Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene 24: 3459-3471 (Pubitemid 40756247)
    • (2005) Oncogene , vol.24 , Issue.21 , pp. 3459-3471
    • Bhatt, K.V.1    Spofford, L.S.2    Aram, G.3    McMullen, M.4    Pumiglia, K.5    Aplin, A.E.6
  • 3
    • 0037147122 scopus 로고    scopus 로고
    • Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation
    • DOI 10.1074/jbc.M208086200
    • Biswas SC, Greene LA (2002) Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation. J Biol Chem 277: 49511-49516 (Pubitemid 36014388)
    • (2002) Journal of Biological Chemistry , vol.277 , Issue.51 , pp. 49511-49516
    • Biswas, S.C.1    Greene, L.A.2
  • 4
    • 43749087380 scopus 로고    scopus 로고
    • V600E signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells
    • DOI 10.1038/sj.onc.1210972, PII 1210972
    • Cui Y, Guadagno TM (2008) B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Oncogene 27: 3122-3133 (Pubitemid 351693167)
    • (2008) Oncogene , vol.27 , Issue.22 , pp. 3122-3133
    • Cui, Y.1    Guadagno, T.M.2
  • 5
    • 55249124825 scopus 로고    scopus 로고
    • Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells
    • Dai Y, Chen S, Pei XY, Almenara JA, Kramer LB, Venditti CA, Dent P, Grant S (2008) Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells. Blood 112: 2439-2449
    • (2008) Blood , vol.112 , pp. 2439-2449
    • Dai, Y.1    Chen, S.2    Pei, X.Y.3    Almenara, J.A.4    Kramer, L.B.5    Venditti, C.A.6    Dent, P.7    Grant, S.8
  • 6
    • 34548097240 scopus 로고    scopus 로고
    • AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: Mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
    • DOI 10.1158/1535-7163.MCT-07-0231
    • Davies BR, Logie A, McKay JS, Martin P, Steele S, Jenkins R, Cockerill M, Cartlidge S, Smith PD (2007) AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models. Mol Cancer Ther 6: 2209-2219 (Pubitemid 47294749)
    • (2007) Molecular Cancer Therapeutics , vol.6 , Issue.8 , pp. 2209-2219
    • Davies, B.R.1    Logie, A.2    McKay, J.S.3    Martin, P.4    Steele, S.5    Jenkins, R.6    Cockerill, M.7    Cartlidge, S.8    Smith, P.D.9
  • 8
    • 3142683869 scopus 로고    scopus 로고
    • MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
    • DOI 10.1038/sj.onc.1207692
    • Domina AM, Vrana JA, Gregory MA, Hann SR, Craig RW (2004) MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23: 5301-5315 (Pubitemid 39005806)
    • (2004) Oncogene , vol.23 , Issue.31 , pp. 5301-5315
    • Domina, A.M.1    Vrana, J.A.2    Gregory, M.A.3    Hann, S.R.4    Craig, R.W.5
  • 10
    • 0033941733 scopus 로고    scopus 로고
    • Temozolomide and treatment of malignant glioma
    • Friedman HS, Kerby T, Calvert H (2000) Temozolomide and treatment of malignant glioma. Clin Cancer Res 6: 2585-2597 (Pubitemid 30482092)
    • (2000) Clinical Cancer Research , vol.6 , Issue.7 , pp. 2585-2597
    • Friedman, H.S.1    Kerby, T.2    Calvert, H.3
  • 11
    • 33847066413 scopus 로고    scopus 로고
    • Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response
    • Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF, Valerie K (2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 67: 1046-1053
    • (2007) Cancer Res , vol.67 , pp. 1046-1053
    • Golding, S.E.1    Rosenberg, E.2    Neill, S.3    Dent, P.4    Povirk, L.F.5    Valerie, K.6
  • 12
    • 40749124035 scopus 로고    scopus 로고
    • The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel
    • DOI 10.1158/1078-0432.CCR-07-1440
    • Haass NK, Sproesser K, Nguyen TK, Contractor R, Medina CA, Nathanson KL, Herlyn M, Smalley KS (2008) The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel. Clin Cancer Res 14: 230-239 (Pubitemid 351378000)
    • (2008) Clinical Cancer Research , vol.14 , Issue.1 , pp. 230-239
    • Haass, N.K.1    Sproesser, K.2    Nguyen, T.K.3    Contractor, R.4    Medina, C.A.5    Nathanson, K.L.6    Herlyn, M.7    Smalley, K.S.M.8
  • 13
    • 0034644702 scopus 로고    scopus 로고
    • Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole
    • Hayne C, Tzivion G, Luo Z (2000) Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J Biol Chem275: 31876-31882
    • (2000) J Biol Chem , vol.275 , pp. 31876-31882
    • Hayne, C.1    Tzivion, G.2    Luo, Z.3
  • 16
    • 0038482050 scopus 로고    scopus 로고
    • Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
    • DOI 10.1074/jbc.M301010200
    • Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ (2003) Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasomedependent degradation of the BH3-only protein, Bim. J Biol Chem 278: 18811-18816 (Pubitemid 36799262)
    • (2003) Journal of Biological Chemistry , vol.278 , Issue.21 , pp. 18811-18816
    • Ley, R.1    Balmanno, K.2    Hadfield, K.3    Weston, C.4    Cook, S.J.5
  • 17
    • 1242272924 scopus 로고    scopus 로고
    • The MAP kinase pathway is required for entry into mitosis and cell survival
    • DOI 10.1038/sj.onc.1207188
    • Liu X, Yan S, Zhou T, Terada Y, Erikson RL (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23: 763-776 (Pubitemid 38241277)
    • (2004) Oncogene , vol.23 , Issue.3 , pp. 763-776
    • Liu, X.1    Yan, S.2    Zhou, T.3    Terada, Y.4    Erikson, R.L.5
  • 19
    • 0242521470 scopus 로고    scopus 로고
    • Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
    • Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G, Auberger P (2003) Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22: 6785-6793 (Pubitemid 37372218)
    • (2003) Oncogene , vol.22 , Issue.REV. ISS. 4 , pp. 6785-6793
    • Luciano, F.1    Jacquel, A.2    Colosetti, P.3    Herrant, M.4    Cagnol, S.5    Pages, G.6    Auberger, P.7
  • 20
    • 0035992286 scopus 로고    scopus 로고
    • Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition
    • MacKeigan JP, Taxman DJ, Hunter D, Earp 3rd HS, Graves LM, Ting JP (2002) Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin Cancer Res 8: 2091-2099 (Pubitemid 34753578)
    • (2002) Clinical Cancer Research , vol.8 , Issue.7 , pp. 2091-2099
    • MacKeigan, J.P.1    Taxman, D.J.2    Hunter, D.3    Earp III, H.S.4    Graves, L.M.5    Ting, J.P.-Y.6
  • 21
    • 0034920013 scopus 로고    scopus 로고
    • Selective potentiation of paclitaxel (Taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines
    • McDaid HM, Horwitz SB (2001) Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol Pharmacol 60: 290-301 (Pubitemid 32678294)
    • (2001) Molecular Pharmacology , vol.60 , Issue.2 , pp. 290-301
    • McDaid, H.M.1    Horwitz, S.B.2
  • 22
    • 16844386676 scopus 로고    scopus 로고
    • Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants
    • DOI 10.1158/0008-5472.CAN-04-4391
    • McDaid HM, Lopez-Barcons L, Grossman A, Lia M, Keller S, Perez-Soler R, Horwitz SB (2005) Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. Cancer Res 65: 2854-2860 (Pubitemid 40490089)
    • (2005) Cancer Research , vol.65 , Issue.7 , pp. 2854-2860
    • McDaid, H.M.1    Lopez-Barcons, L.2    Grossman, A.3    Lia, M.4    Keller, S.5    Perez-Soler, R.6    Horwitz, S.B.7
  • 25
    • 0032747134 scopus 로고    scopus 로고
    • Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
    • Scheid MP, Schubert KM, Duronio V (1999) Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 274: 31108-31113
    • (1999) J Biol Chem , vol.274 , pp. 31108-31113
    • Scheid, M.P.1    Schubert, K.M.2    Duronio, V.3
  • 26
    • 10344258041 scopus 로고    scopus 로고
    • Targeting the mitogen-activated protein kinase cascade to treat cancer
    • DOI 10.1038/nrc1503
    • Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947 (Pubitemid 39626217)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.12 , pp. 937-947
    • Sebolt-Leopold, J.S.1    Herrera, R.2
  • 27
    • 26644449670 scopus 로고    scopus 로고
    • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    • DOI 10.1016/j.ccr.2005.09.006, PII S1535610805002990
    • She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N (2005) The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8: 287-297 (Pubitemid 41443414)
    • (2005) Cancer Cell , vol.8 , Issue.4 , pp. 287-297
    • She, Q.-B.1    Solit, D.B.2    Ye, Q.3    O'Reilly, K.E.4    Lobo, J.5    Rosen, N.6
  • 31
    • 4444251799 scopus 로고    scopus 로고
    • Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro
    • Yacoub A, Han SI, Caron R, Gilfor D, Mooberry S, Grant S, Dent P (2003) Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro. Cancer Biol Ther 2: 670-676
    • (2003) Cancer Biol Ther , vol.2 , pp. 670-676
    • Yacoub, A.1    Han, S.I.2    Caron, R.3    Gilfor, D.4    Mooberry, S.5    Grant, S.6    Dent, P.7
  • 32
    • 34447537796 scopus 로고    scopus 로고
    • Irradiation-induced G2/M checkpoint response requires ERK1/2 activation
    • DOI 10.1038/sj.onc.1210268, PII 1210268
    • Yan Y, Black CP, Cowan KH (2007) Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 26: 4689-4698 (Pubitemid 47067411)
    • (2007) Oncogene , vol.26 , Issue.32 , pp. 4689-4698
    • Yan, Y.1    Black, C.P.2    Cowan, K.H.3
  • 33
    • 0034948613 scopus 로고    scopus 로고
    • Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway
    • Yu C, Wang S, Dent P, Grant S (2001) Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Mol Pharmacol 60: 143-154 (Pubitemid 32595242)
    • (2001) Molecular Pharmacology , vol.60 , Issue.1 , pp. 143-154
    • Yu, C.1    Wang, S.2    Dent, P.3    Grant, S.4
  • 34
    • 33750611606 scopus 로고    scopus 로고
    • Mps1 Phosphorylation by MAP Kinase Is Required for Kinetochore Localization of Spindle-Checkpoint Proteins
    • DOI 10.1016/j.cub.2006.07.058, PII S0960982206019634
    • Zhao Y, Chen RH (2006) Mps1 phosphorylation by MAP kinase is required for kinetochore localization of spindle-checkpoint proteins. Curr Biol 16: 1764-1769 (Pubitemid 44691789)
    • (2006) Current Biology , vol.16 , Issue.17 , pp. 1764-1769
    • Zhao, Y.1    Chen, R.-H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.